As of 2025-09-18, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 13.6x | 11.0x |
| Forward P/E multiples | 12.3x - 19.2x | 15.8x |
| Fair Price | (154.24) - (169.67) | (167.00) |
| Upside | -3203.3% - -3513.8% | -3460.1% |
| Date | EV/EBITDA |